Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Rocco Piazza remains committed to offering BPC 157 in oral form
The strongest evidence is preclinical but directly tests NNMT inhibition in metabolic disease models
Subjects with obesity: significantly higher NNMT activity in adipose tissue and liver
Regulatory Considerations Current Regulatory Status and Legal Framework The regulatory status of BPC-157 and TB-500 varies significantly across different jurisdictions and continues to evolve as regulatory agencies assess these compounds
This article does not diagnose, treat, or prescribe
US$ 28.87
US$ 25.40
US$ 29.77
